These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Antibacterial properties of gemifloxacin and trovafloxacin in urine ex vivo: phase I study.
    Author: García-Calvo G, Parra A, Aguilar L, Ponte C, Giménez MJ, Carcas A, Kinzig-Schippers M, Soriano F.
    Journal: Antimicrob Agents Chemother; 2001 Jun; 45(6):1876-8. PubMed ID: 11353641.
    Abstract:
    Urine bactericidal titers (UBTs) against Escherichia coli ATCC 25922 and Staphylococcus saprophyticus ATCC 1970 were determined after the administration of single oral doses of gemifloxacin at 320 mg and trovafloxacin at 200 mg to healthy volunteers. Gemifloxacin presented significantly lower experimental versus mathematically predicted UBTs over 72 h, due to the effect of urine on the susceptibility of the E. coli strain. Experimental UBTs were significantly higher for gemifloxacin than trovafloxacin against both strains over 72 h.
    [Abstract] [Full Text] [Related] [New Search]